1. Home
  2. KALA vs DAIO Comparison

KALA vs DAIO Comparison

Compare KALA & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • DAIO
  • Stock Information
  • Founded
  • KALA 2009
  • DAIO 1969
  • Country
  • KALA United States
  • DAIO United States
  • Employees
  • KALA N/A
  • DAIO N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • DAIO Electrical Products
  • Sector
  • KALA Health Care
  • DAIO Industrials
  • Exchange
  • KALA Nasdaq
  • DAIO Nasdaq
  • Market Cap
  • KALA 26.2M
  • DAIO 22.0M
  • IPO Year
  • KALA 2017
  • DAIO N/A
  • Fundamental
  • Price
  • KALA $4.87
  • DAIO $3.08
  • Analyst Decision
  • KALA Strong Buy
  • DAIO Strong Buy
  • Analyst Count
  • KALA 3
  • DAIO 1
  • Target Price
  • KALA $14.00
  • DAIO $4.00
  • AVG Volume (30 Days)
  • KALA 64.7K
  • DAIO 38.1K
  • Earning Date
  • KALA 08-05-2025
  • DAIO 07-24-2025
  • Dividend Yield
  • KALA N/A
  • DAIO N/A
  • EPS Growth
  • KALA N/A
  • DAIO N/A
  • EPS
  • KALA N/A
  • DAIO N/A
  • Revenue
  • KALA N/A
  • DAIO $21,846,000.00
  • Revenue This Year
  • KALA N/A
  • DAIO $7.06
  • Revenue Next Year
  • KALA N/A
  • DAIO $5.39
  • P/E Ratio
  • KALA N/A
  • DAIO N/A
  • Revenue Growth
  • KALA N/A
  • DAIO N/A
  • 52 Week Low
  • KALA $2.92
  • DAIO $1.88
  • 52 Week High
  • KALA $11.20
  • DAIO $3.14
  • Technical
  • Relative Strength Index (RSI)
  • KALA 55.88
  • DAIO 65.34
  • Support Level
  • KALA $4.36
  • DAIO $2.70
  • Resistance Level
  • KALA $5.90
  • DAIO $3.12
  • Average True Range (ATR)
  • KALA 0.48
  • DAIO 0.12
  • MACD
  • KALA 0.05
  • DAIO 0.01
  • Stochastic Oscillator
  • KALA 39.81
  • DAIO 84.52

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: